PBF-509
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PBF-509, covering 2016-03-08 to 2016-03-08. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers [Phase 1]